ArticleInternational journal of radiation oncology, biology, physics2026
Causal Machine Learning Analysis of Empirical Relative Biological Effectiveness for Mandible Osteoradionecrosis in Head and Neck Cancer Radiation Therapy.
Article in International journal of radiation oncology, biology, physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Update of
Authors and funding
11 authors.
Funding
Abstract
purposeOsteoradionecrosis (ORN) of the mandible is one of the most severe adverse events for head and neck (H&N) cancer radiation therapy. Previous retrospective investigations on real-world data relied heavily on conventional statistical models that primarily elucidate correlation rather than establishing causal relationships. Through the novel causal machine learning method, we aim to obtain empirical relative biological effectiveness (RBE) for mandible ORN in patients with H&N cancer treated with pencil-beam-scanning proton therapy (PBSPT). METHODS AND MATERIALS: A total of 1266 patients with H&N cancer were included: 335 patients treated by PBSPT and 931 patients treated by volumetric modulated arc therapy (VMAT). We used 1:1 propensity-score case matching to minimize imbalance in clinical factors between patients treated with PBSPT and VMAT. Standardized mean differences were used to assess residual clinical-factor imbalance within the case-matched cohorts. Causal forest (CF) was adopted to investigate the causal effects between dosimetric factors and the incidence of ORN. For each modality and each prespecified dose-volume histogram (DVH) index, candidate dose-volume thresholds were evaluated systematically, and the volume threshold yielding the largest CF-estimated average treatment effect was selected as the dose-volume constraint (DVC) volume threshold. Empirical RBE values were derived from equal-volume intersections on modality-specific volume-tolerance curves after converting PBSPT Gy[RBE] values to physical dose.
resultsA total of 335 VMAT patients were case-matched to 335 patients treated by PBSPT; however, standardized mean bias analysis revealed persistent covariate imbalances within each group, indicating residual confounding influence. Using CF modeling, we identified candidate DVC volume thresholds for mandibular ORN and found that PBSPT had lower selected DVC volume thresholds than VMAT. The threshold-stability analyses supported the robustness of the DVC thresholds emphasized in the empirical RBE analysis. The resulting empirical RBE exceeded 1.1 in the moderate dose range (1.61 at 40 Gy[RBE], 1.30 at 50 Gy[RBE], and 1.13 at 60 Gy[RBE]).
conclusionsThis study presents a novel application of causal machine learning to evaluate mandibular ORN in radiation therapy, identifying candidate DVC volume thresholds linked to the strongest threshold-defined causal effects and deriving empirical RBEs from equal-volume equivalent constraint dose analysis based on volume-tolerance curves. The results indicate that proton RBE may exceed 1.1 in the moderate dose range (40-60 Gy[RBE]), underscoring the importance of considering endpoint-specific variable RBE in PBSPT treatment planning. These CF-identified DVC volume thresholds should be interpreted as hypothesis-generating risk regions rather than definitive clinical cutoffs, pending independent prospective validation.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.